Screener
Core Scientific, Inc. CORZ Cash Flow Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| -$1.16B-23.3% | -$347.19M-160% | —— | -$146.66M+67.8% | -$936.8M-3.8% | ||
| $15.5M-17.4% | $16.65M-15.6% | $14.1M-45.9% | $16.33M-43.1% | $18.76M-36.4% | ||
| $18.24M-24.5% | $17.76M+9.7% | $27.94M+16.6% | $29.95M+45.9% | $24.17M+185% | ||
| —— | $249.88M+715% | $153.07M+1,009% | $131.78M+2,207% | $34M+2,724% | ||
| $565.02M+366% | $389.23M+340% | $274.81M+856% | $244.49M+684% | $121.28M+3,769% | ||
| -$796.24M-566% | -$386.65M-314% | -$273.33M-849% | -$254.36M-714% | -$119.61M-3,657% | ||
| $3.28B— | $995M— | $0+100% | $0— | $0— | ||
| $0-100% | $0-100% | —— | —— | $4.66M-68.2% | ||
| $2.22B+7,089% | $971.38M+23,239% | -$21.81M-104% | -$5.32M-103% | -$31.77M— | ||
| $1.41B+1,297% | $834.61M+704% | -$142.07M-124% | -$127.9M-182% | -$117.38M— | ||
| -$583.95M-569% | -$139.35M-8.0% | -$121.74M-714% | -$112.71M-343% | -$87.28M-4,420% |
FAQ
- What is Core Scientific, Inc.'s free cash flow?
- After $1.5B of capital expenditures, Core Scientific, Inc.'s free cash flow was -$957.7M over the trailing twelve months, down 273.1% year over year.
- Where does Core Scientific, Inc.'s cash flow data come from?
- Every line is extracted from Core Scientific, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
